Overview

Changes in Myocardial Biomechanics and Early Short-term Doxycycline Therapy in Patients With Primary Anterior STEMI

Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to investigate the changes of myocardial biomechanics and efficacy of doxycycline in patients with primary anterior STEMI.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Russian Academy of Medical Sciences
Treatments:
Doxycycline
Criteria
Inclusion Criteria:

- age ≥ 18 and ≤ 75 years at time of randomization (18 years and older)

- ST-elevation Q wave myocardial infarction

- term admission to an intensive care unit (ICU) in the first 24 hours of onset

- the reperfusion of the infarct-related coronary artery is not later than 24 hours
after the initial onset of acute transmural myocardial infarction

- written the informed consent to participate in research

Exclusion Criteria:

- atrial fibrillation, a permanent form

- valvular heart disease

- severe comorbidity

- acute heart failure according to the Killip classification IV FC (functional class)

- history of chronic heart failure (NYHA III-IV)

- poor image quality for Echocardiography

- sinus bradycardia - heart rate of under 50 beats per minute, interventricular
conduction delay (QRS > 0,11 s.) and atrioventricular block II-III degree